The ALEX RS is a bilateral upper-limb exoskeleton designed for post-stroke rehabilitation, covering 92% of the human arm's natural range of motion and is CE certified as a Class IIa medical device.
You just have to immerse yourself in it. You should just constantly be building. That's what's going to give you the best chance of having the relevant skill set that is needed to make a difference in technology.
Modern scientific societies are increasingly vulnerable due to their dependence on membership fees and journal subscriptions, which are being challenged by the rise of virtual networking and open-access publishing.
In the AI era, it should be easier than ever for people to build new businesses. We want to build the services that enable this. This is important for ensuring that people broadly share in the prosperity created by superintelligence.
Incyte tops this list due to its rare combination of commercial scale, cash generation, and pipeline depth. The company posted FY2025 revenue of $5.14 billion, up 21.2% YoY, anchored by Jakafi generating $828.2 million in Q4 2025 alone (+7% YoY) and Opzelura delivering $207.3 million (+28% YoY). With $3.58 billion in cash and 14 pivotal clinical trials underway, Incyte offers an acquirer immediate revenue, margin expansion potential, and a deep oncology pipeline spanning KRASG12D, CDK2 inhibition, and mutCALR.
Over two-thirds said they recommend their students consider careers outside academia. The majority had delayed hiring in their labs, and one-third had laid off workers. More than one in six said they have lost researchers to institutions in other countries since Trump took office. Sixty-eight percent said funding cuts and federal policy changes had moderately or significantly reduced the scope of their work.
But he'd been considering an idea for new technology-an autonomous, wind-powered cargo ship. Then, while on paternity leave in 2024, he discovered a free program that helps scientists and engineers launch businesses for the first time. Weeks after finishing the program, called 5050, Cymbalist had launched a startup called Clippership. The company's first ship is being built in the Netherlands this year. Without the accelerator, he says, the company likely wouldn't exist.
For nearly 100 years, the United States has been the world's leader in a wide variety of scientific fields. No other country has: invested as much in fundamental scientific research, has made more scientific breakthroughs and scientific advances, has attracted more scientific researchers to move there to conduct their research, or has conducted more projects and been home to more scientists that have won Nobel Prizes.
